Terumo India Launches FineCross™ M3 to Strengthen Interventional Cardiology Portfolio

The new-generation device is designed to enhance crossing ability, guidewire support, and navigability in complex percutaneous coronary intervention (PCI) cases.

Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), announced the launch of its FineCross™ M3 Coronary Micro-Guide Catheter in India. 

The new-generation device is designed to enhance crossing ability, guidewire support, and navigability in complex percutaneous coronary intervention (PCI) cases.

With coronary artery disease (CAD) remaining the leading cause of death in India and an increasing number of patients presenting with complex lesions, the company stated that FineCross™ M3 aims to equip cardiologists with advanced tools to perform safer and more predictable PCI procedures.

Commenting on the launch, Shishir Agarwal, President and Managing Director, Terumo India, said, “Innovation at Terumo India is always guided by enabling physicians to deliver the best possible care to patients. With the launch of FineCross™ M3, we are proud to bring a globally trusted advancement in interventional cardiology to India. This milestone reflects not only our commitment to strengthening cardiovascular care in the country, but also our Promise's Unwavering commitment to patients that lies at the heart of everything we do.”

The FineCross™ M3 integrates Terumo’s engineering expertise with new design enhancements addressing real-world challenges in PCI. Its features include a 1.7 Fr tapered distal tip for superior lesion crossability, a 15 cm floppy distal segment for trackability, a tapered stainless-steel braided shaft for pushability and control, next-generation hydrophilic coating for lubrication and durability, and a PTFE inner layer with a radiopaque marker for smoother device delivery and visualization.

Adding further perspective, Nitin Stephen Abel, Senior Director, Terumo Interventional Systems, Terumo India, said, “FineCross™ M3 represents more than just a product launch; it reflects our continued focus on advancing cardiovascular care in India in line with Terumo’s mission of contributing to society through healthcare. Through globally trusted innovations, we aim to empower physicians in delivering better patient outcomes and create a meaningful impact where it matters most.”

The launch adds to Terumo India’s expanding interventional cardiology portfolio, reinforcing its role in providing advanced cardiovascular solutions across the country.

Stay tuned for more such updates on Digital Health News